查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1856174

肾上腺皮质荷尔蒙原料药：全球市占率排名、总销售额与需求预测（2025-2031年）

Adrenocortical Hormones API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球肾上腺皮质荷尔蒙原料药市场规模预计为25.8亿美元，预计到2031年将达到38.92亿美元，在2025-2031年的预测期内，复合年增长率将达到6.2%。

原料药肾上腺皮质荷尔蒙（API）是指用于生产皮质类固醇药物的原料。这些荷尔蒙在肾上腺皮质合成，在调节新陈代谢、免疫反应和压力适应方面发挥重要作用。常见的皮质肾上腺皮质荷尔蒙药物成分包括Hydrocortisone可的松、泼尼松、地塞米松和Betamethasone，广泛用于治疗发炎性疾病、自体免疫疾病和内分泌功能障碍。这些活性原料药的生产涉及复杂的化学合成或半合成过程，其原料为甾体前体，通常来自植物固醇。由于其重要的医疗用途，肾上腺皮质荷尔蒙活性药物成分必须经过严格的品管和监管，以确保其疗效和安全性。

肾上腺皮质荷尔蒙製剂广泛用于抗发炎、免疫抑制和内分泌疾病的治疗，市场需求持续成长。历史上，全球类固醇製药业一直由辉瑞、拜耳、默克和赛诺菲等西方大型跨国製药公司主导。这些公司拥有关键技术，并在高端市场占据强大地位。然而，近年来，凭藉肾上腺皮质荷尔蒙。随着製药业的全球化进程不断推进，类固醇供应链也不断优化。中国製造商正积极推动产业升级和品管，推动产业走向更标准化和高附加价值。此外，更严格的环境法规和更高的生产标准也促使企业追求绿色生产和完善合规管理，进一步增强了中国在全球市场的竞争力。此外，全球人口老化和慢性病盛行率上升预计将持续推高对皮质类固醇製剂的需求，为该产业带来更多成长机会。首先，肾上腺皮质荷尔蒙和化学合成技术的突破降低了生产成本，并增强了国际竞争力。其次，中国製造商在品管和国际认证方面取得了显着进展，这有助于其进入欧美高端市场。此外，跨国製药公司越来越依赖中国供应商来优化生产成本和供应链效率，加速了该产业向中国的转移。全球环境法规的日益严格推高了部分製造商的营运成本。此外，国际贸易政策和智慧财产权保护的变化可能会影响中国企业的出口竞争力。而且，高端市场仍有技术壁垒，要求中国企业进一步投资核心专利、品牌影响力以及高级产品研发。

本报告旨在全面概述全球肾上腺皮质荷尔蒙原料药市场，重点关注总销售量、销售收入、价格、市场份额和主要企业的排名，并按地区/国家、类型和应用分析肾上腺皮质荷尔蒙原料药。

肾上腺皮质荷尔蒙以销售量（吨）和销售收入（百万美元）为单位，提供皮质类固醇原料药市场规模、估算和预测，以2024年为基准年，并提供2020年至2031年的历史数据和预测数据。定量和定性分析有助于读者制定业务/成长策略、评估竞争格局、分析公司在当前市场中的地位，并就肾上腺皮质荷尔蒙原料药做出明智的商业决策。

目录

第一章 市场概览

  • 肾上腺皮质荷尔蒙原料药产品介绍
  • 全球肾上腺皮质荷尔蒙原料药市场规模预测
  • 肾上腺皮质荷尔蒙原料药市场趋势及驱动因素
  • 前提条件和限制条件
  • 调查目的
  • 多年的考虑

第二章 公司竞争分析

  • 全球肾上腺皮质荷尔蒙原料药公司营收排名（2024 年）
  • 全球肾上腺皮质荷尔蒙原料药收入（按公司划分）（2020-2025 年）
  • 全球肾上腺皮质荷尔蒙原料药销售额排名（2024 年）
  • 全球肾上腺皮质荷尔蒙原料药销售额（按公司分列）（2020-2025 年）
  • 全球肾上腺皮质荷尔蒙原料药平均价格（按公司划分）（2020-2025 年）
  • 主要肾上腺皮质荷尔蒙原料药製造地和总部
  • 主要生产商的肾上腺皮质荷尔蒙原料药产品供应情况
  • 大型生产者何时开始大规模生产皮质肾上腺皮质荷尔蒙原料药？
  • 肾上腺皮质荷尔蒙原料药市场竞争分析
  • 併购、业务扩张

第三章 依类型细分

  • 按类型介绍
    • 泼尼松系列
    • 地塞米松系列
    • Betamethasone系列
    • Hydrocortisone系列
    • 其他的
  • 全球肾上腺皮质荷尔蒙原料药销售额（按类型划分）
  • 全球肾上腺皮质荷尔蒙原料药销售量）
  • 全球肾上腺皮质荷尔蒙原料药平均价格（按类型划分）（2020-2031 年）

第四章 按应用进行细分

  • 透过申请
    • 注射
    • 口服
    • 外用药物
    • 吸入药物
  • 全球肾上腺皮质荷尔蒙原料药销售额（按应用领域划分）
  • 全球肾上腺皮质荷尔蒙原料药销售量）
  • 全球肾上腺皮质荷尔蒙原料药平均价格（按应用领域划分）（2020-2031 年）

第五章 区域细分

  • 全球肾上腺皮质荷尔蒙原料药销售额（按地区划分）
  • 全球肾上腺皮质荷尔蒙原料药销售量）
  • 全球肾上腺皮质荷尔蒙原料药平均价格（按地区划分）（2020-2031 年）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东和非洲

第六章 按主要国家划分

  • 主要国家和地区肾上腺皮质荷尔蒙原料药销售额成长趋势，2020 年、2024 年和 2031 年对比
  • 主要国家和地区肾上腺皮质荷尔蒙原料药的销售额和销售量
  • 美国
  • 欧洲
  • 中国
  • 日本
  • 韩国
  • 东南亚
  • 印度

第七章 公司简介

  • Pfizer CentreOne
  • EUROAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid SpA
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Cipla
  • Wellona Pharma
  • Tianjin Tianyao Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical
  • Guangdong Vtr Bio-Tech
  • Zhejiang Xianju Xianle Pharmaceutical
  • TIANJIN PACIFIC PHARMACEUTICAL
  • Shandong Xinhua Pharmaceutica Group
  • Jiangsu Lianhuan Pharmaceutical
  • Shanghai New Hualian Pharmaceutical
  • Shandong Taihua Biotech
  • Saituo Biological Technology
  • Zhejiang Xianju Junye Pharmaceutical

第八章：产业链分析

第九章 研究结果与结论

第十章附录

The global market for Adrenocortical Hormones API was estimated to be worth US$ 2580 million in 2024 and is forecast to a readjusted size of US$ 3892 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Adrenocortical hormones active pharmaceutical ingredients (APIs) refer to the raw materials used in the production of corticosteroid drugs. These hormones are synthesized in the adrenal cortex and play a crucial role in regulating metabolism, immune response, and stress adaptation. Common adrenocortical hormone APIs include hydrocortisone, prednisone, dexamethasone, and betamethasone, which are widely used in the treatment of inflammatory diseases, autoimmune disorders, and endocrine dysfunctions. The production of these APIs involves complex chemical synthesis or semi-synthetic processes derived from steroid precursors, often sourced from plant sterols. Due to their essential medical applications, adrenocortical hormone APIs are subject to strict quality control and regulatory compliance to ensure their efficacy and safety.

Adrenocortical hormone drugs are widely used for anti-inflammatory, immunosuppressive, and endocrine disease treatments, with stable and growing market demand. Historically, the global steroid drug industry has been dominated by major multinational pharmaceutical companies from Europe and the United States, such as Pfizer, Bayer, Merck, and Sanofi. These companies hold key technologies and have a strong presence in high-end markets. However, in recent years, China has emerged as a major production hub for steroid drugs due to its advantages in raw material supply, lower production costs, and continuous improvements in manufacturing technology. As a result, China has become an increasingly significant player in the global adrenocortical hormone API market.As the pharmaceutical industry continues to globalize, the supply chain for steroid drugs is becoming more optimized. Chinese manufacturers are advancing in industrial upgrading and quality control, driving the sector towards greater standardization and higher value-added products. Additionally, stricter environmental regulations and improved production standards are pushing companies toward green manufacturing and better compliance management, further strengthening China's competitiveness in the global market. Moreover, rising aging populations and increasing prevalence of chronic diseases worldwide are expected to sustain demand for adrenocortical hormone drugs, creating further growth opportunities for the industry.Several factors are driving the industry's growth. Firstly, breakthroughs in fermentation and chemical synthesis technologies have lowered production costs, enhancing global competitiveness. Secondly, Chinese manufacturers have made significant progress in quality control and international certifications, enabling easier entry into high-end markets in Europe and the United States. Additionally, multinational pharmaceutical companies are increasingly relying on Chinese suppliers to optimize their production costs and supply chain efficiency, accelerating the industry's shift toward China.However, the industry also faces challenges. Stricter environmental regulations worldwide are increasing operational costs for some manufacturers. Additionally, changes in international trade policies and intellectual property rights protection could impact Chinese companies' export competitiveness. Furthermore, technical barriers in high-end markets remain, requiring Chinese companies to further invest in core patents, brand influence, and premium product development.

This report aims to provide a comprehensive presentation of the global market for Adrenocortical Hormones API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Adrenocortical Hormones API by region & country, by Type, and by Application.

The Adrenocortical Hormones API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adrenocortical Hormones API.

Market Segmentation

By Company

  • Pfizer CentreOne
  • EUROAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid SpA
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Cipla
  • Wellona Pharma
  • Tianjin Tianyao Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical
  • Guangdong Vtr Bio-Tech
  • Zhejiang Xianju Xianle Pharmaceutical
  • TIANJIN PACIFIC PHARMACEUTICAL
  • Shandong Xinhua Pharmaceutica Group
  • Jiangsu Lianhuan Pharmaceutical
  • Shanghai New Hualian Pharmaceutical
  • Shandong Taihua Biotech
  • Saituo Biological Technology
  • Zhejiang Xianju Junye Pharmaceutical

Segment by Type

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Segment by Application

  • Injectable Drugs
  • Oral Drugs
  • Topical Drugs
  • Inhaled Drugs

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Adrenocortical Hormones API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Adrenocortical Hormones API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Adrenocortical Hormones API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Adrenocortical Hormones API Product Introduction
  • 1.2 Global Adrenocortical Hormones API Market Size Forecast
    • 1.2.1 Global Adrenocortical Hormones API Sales Value (2020-2031)
    • 1.2.2 Global Adrenocortical Hormones API Sales Volume (2020-2031)
    • 1.2.3 Global Adrenocortical Hormones API Sales Price (2020-2031)
  • 1.3 Adrenocortical Hormones API Market Trends & Drivers
    • 1.3.1 Adrenocortical Hormones API Industry Trends
    • 1.3.2 Adrenocortical Hormones API Market Drivers & Opportunity
    • 1.3.3 Adrenocortical Hormones API Market Challenges
    • 1.3.4 Adrenocortical Hormones API Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Adrenocortical Hormones API Players Revenue Ranking (2024)
  • 2.2 Global Adrenocortical Hormones API Revenue by Company (2020-2025)
  • 2.3 Global Adrenocortical Hormones API Players Sales Volume Ranking (2024)
  • 2.4 Global Adrenocortical Hormones API Sales Volume by Company Players (2020-2025)
  • 2.5 Global Adrenocortical Hormones API Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Adrenocortical Hormones API Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Adrenocortical Hormones API Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Adrenocortical Hormones API
  • 2.9 Adrenocortical Hormones API Market Competitive Analysis
    • 2.9.1 Adrenocortical Hormones API Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Adrenocortical Hormones API Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Prednisone Series
    • 3.1.2 Dexamethasone Series
    • 3.1.3 Betamethasone Series
    • 3.1.4 Hydrocortisone Series
    • 3.1.5 Others
  • 3.2 Global Adrenocortical Hormones API Sales Value by Type
    • 3.2.1 Global Adrenocortical Hormones API Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Adrenocortical Hormones API Sales Value, by Type (2020-2031)
    • 3.2.3 Global Adrenocortical Hormones API Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Adrenocortical Hormones API Sales Volume by Type
    • 3.3.1 Global Adrenocortical Hormones API Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Adrenocortical Hormones API Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Adrenocortical Hormones API Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Adrenocortical Hormones API Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Injectable Drugs
    • 4.1.2 Oral Drugs
    • 4.1.3 Topical Drugs
    • 4.1.4 Inhaled Drugs
  • 4.2 Global Adrenocortical Hormones API Sales Value by Application
    • 4.2.1 Global Adrenocortical Hormones API Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Adrenocortical Hormones API Sales Value, by Application (2020-2031)
    • 4.2.3 Global Adrenocortical Hormones API Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Adrenocortical Hormones API Sales Volume by Application
    • 4.3.1 Global Adrenocortical Hormones API Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Adrenocortical Hormones API Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Adrenocortical Hormones API Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Adrenocortical Hormones API Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Adrenocortical Hormones API Sales Value by Region
    • 5.1.1 Global Adrenocortical Hormones API Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Adrenocortical Hormones API Sales Value by Region (2020-2025)
    • 5.1.3 Global Adrenocortical Hormones API Sales Value by Region (2026-2031)
    • 5.1.4 Global Adrenocortical Hormones API Sales Value by Region (%), (2020-2031)
  • 5.2 Global Adrenocortical Hormones API Sales Volume by Region
    • 5.2.1 Global Adrenocortical Hormones API Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Adrenocortical Hormones API Sales Volume by Region (2020-2025)
    • 5.2.3 Global Adrenocortical Hormones API Sales Volume by Region (2026-2031)
    • 5.2.4 Global Adrenocortical Hormones API Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Adrenocortical Hormones API Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.4.2 North America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.5.2 Europe Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Adrenocortical Hormones API Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.7.2 South America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Adrenocortical Hormones API Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Adrenocortical Hormones API Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Adrenocortical Hormones API Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Adrenocortical Hormones API Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.3.2 United States Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.4.2 Europe Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.5.2 China Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.6.2 Japan Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.7.2 South Korea Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Adrenocortical Hormones API Sales Value, 2020-2031
    • 6.9.2 India Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Pfizer CentreOne
    • 7.1.1 Pfizer CentreOne Company Information
    • 7.1.2 Pfizer CentreOne Introduction and Business Overview
    • 7.1.3 Pfizer CentreOne Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Pfizer CentreOne Adrenocortical Hormones API Product Offerings
    • 7.1.5 Pfizer CentreOne Recent Development
  • 7.2 EUROAPI
    • 7.2.1 EUROAPI Company Information
    • 7.2.2 EUROAPI Introduction and Business Overview
    • 7.2.3 EUROAPI Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 EUROAPI Adrenocortical Hormones API Product Offerings
    • 7.2.5 EUROAPI Recent Development
  • 7.3 GlaxoSmithKline
    • 7.3.1 GlaxoSmithKline Company Information
    • 7.3.2 GlaxoSmithKline Introduction and Business Overview
    • 7.3.3 GlaxoSmithKline Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 GlaxoSmithKline Adrenocortical Hormones API Product Offerings
    • 7.3.5 GlaxoSmithKline Recent Development
  • 7.4 Teva Pharmaceutical Industries
    • 7.4.1 Teva Pharmaceutical Industries Company Information
    • 7.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
    • 7.4.3 Teva Pharmaceutical Industries Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Teva Pharmaceutical Industries Adrenocortical Hormones API Product Offerings
    • 7.4.5 Teva Pharmaceutical Industries Recent Development
  • 7.5 Hovione
    • 7.5.1 Hovione Company Information
    • 7.5.2 Hovione Introduction and Business Overview
    • 7.5.3 Hovione Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hovione Adrenocortical Hormones API Product Offerings
    • 7.5.5 Hovione Recent Development
  • 7.6 Axplora
    • 7.6.1 Axplora Company Information
    • 7.6.2 Axplora Introduction and Business Overview
    • 7.6.3 Axplora Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Axplora Adrenocortical Hormones API Product Offerings
    • 7.6.5 Axplora Recent Development
  • 7.7 Steroid SpA
    • 7.7.1 Steroid SpA Company Information
    • 7.7.2 Steroid SpA Introduction and Business Overview
    • 7.7.3 Steroid SpA Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Steroid SpA Adrenocortical Hormones API Product Offerings
    • 7.7.5 Steroid SpA Recent Development
  • 7.8 Avik Pharmaceutical
    • 7.8.1 Avik Pharmaceutical Company Information
    • 7.8.2 Avik Pharmaceutical Introduction and Business Overview
    • 7.8.3 Avik Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Avik Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.8.5 Avik Pharmaceutical Recent Development
  • 7.9 Anuh Pharma
    • 7.9.1 Anuh Pharma Company Information
    • 7.9.2 Anuh Pharma Introduction and Business Overview
    • 7.9.3 Anuh Pharma Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Anuh Pharma Adrenocortical Hormones API Product Offerings
    • 7.9.5 Anuh Pharma Recent Development
  • 7.10 Symbiotec Pharmalab
    • 7.10.1 Symbiotec Pharmalab Company Information
    • 7.10.2 Symbiotec Pharmalab Introduction and Business Overview
    • 7.10.3 Symbiotec Pharmalab Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Symbiotec Pharmalab Adrenocortical Hormones API Product Offerings
    • 7.10.5 Symbiotec Pharmalab Recent Development
  • 7.11 Sun Pharmaceutical
    • 7.11.1 Sun Pharmaceutical Company Information
    • 7.11.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.11.3 Sun Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Sun Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.11.5 Sun Pharmaceutical Recent Development
  • 7.12 Cipla
    • 7.12.1 Cipla Company Information
    • 7.12.2 Cipla Introduction and Business Overview
    • 7.12.3 Cipla Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Cipla Adrenocortical Hormones API Product Offerings
    • 7.12.5 Cipla Recent Development
  • 7.13 Wellona Pharma
    • 7.13.1 Wellona Pharma Company Information
    • 7.13.2 Wellona Pharma Introduction and Business Overview
    • 7.13.3 Wellona Pharma Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Wellona Pharma Adrenocortical Hormones API Product Offerings
    • 7.13.5 Wellona Pharma Recent Development
  • 7.14 Tianjin Tianyao Pharmaceuticals
    • 7.14.1 Tianjin Tianyao Pharmaceuticals Company Information
    • 7.14.2 Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
    • 7.14.3 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Offerings
    • 7.14.5 Tianjin Tianyao Pharmaceuticals Recent Development
  • 7.15 Zhejiang Xianju Pharmaceutical
    • 7.15.1 Zhejiang Xianju Pharmaceutical Company Information
    • 7.15.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview
    • 7.15.3 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.15.5 Zhejiang Xianju Pharmaceutical Recent Development
  • 7.16 Guangdong Vtr Bio-Tech
    • 7.16.1 Guangdong Vtr Bio-Tech Company Information
    • 7.16.2 Guangdong Vtr Bio-Tech Introduction and Business Overview
    • 7.16.3 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Offerings
    • 7.16.5 Guangdong Vtr Bio-Tech Recent Development
  • 7.17 Zhejiang Xianju Xianle Pharmaceutical
    • 7.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
    • 7.17.2 Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
    • 7.17.3 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Development
  • 7.18 TIANJIN PACIFIC PHARMACEUTICAL
    • 7.18.1 TIANJIN PACIFIC PHARMACEUTICAL Company Information
    • 7.18.2 TIANJIN PACIFIC PHARMACEUTICAL Introduction and Business Overview
    • 7.18.3 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Offerings
    • 7.18.5 TIANJIN PACIFIC PHARMACEUTICAL Recent Development
  • 7.19 Shandong Xinhua Pharmaceutica Group
    • 7.19.1 Shandong Xinhua Pharmaceutica Group Company Information
    • 7.19.2 Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
    • 7.19.3 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Offerings
    • 7.19.5 Shandong Xinhua Pharmaceutica Group Recent Development
  • 7.20 Jiangsu Lianhuan Pharmaceutical
    • 7.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
    • 7.20.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
    • 7.20.3 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Development
  • 7.21 Shanghai New Hualian Pharmaceutical
    • 7.21.1 Shanghai New Hualian Pharmaceutical Company Information
    • 7.21.2 Shanghai New Hualian Pharmaceutical Introduction and Business Overview
    • 7.21.3 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.21.5 Shanghai New Hualian Pharmaceutical Recent Development
  • 7.22 Shandong Taihua Biotech
    • 7.22.1 Shandong Taihua Biotech Company Information
    • 7.22.2 Shandong Taihua Biotech Introduction and Business Overview
    • 7.22.3 Shandong Taihua Biotech Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.22.4 Shandong Taihua Biotech Adrenocortical Hormones API Product Offerings
    • 7.22.5 Shandong Taihua Biotech Recent Development
  • 7.23 Saituo Biological Technology
    • 7.23.1 Saituo Biological Technology Company Information
    • 7.23.2 Saituo Biological Technology Introduction and Business Overview
    • 7.23.3 Saituo Biological Technology Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.23.4 Saituo Biological Technology Adrenocortical Hormones API Product Offerings
    • 7.23.5 Saituo Biological Technology Recent Development
  • 7.24 Zhejiang Xianju Junye Pharmaceutical
    • 7.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
    • 7.24.2 Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
    • 7.24.3 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.24.4 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Offerings
    • 7.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Adrenocortical Hormones API Industrial Chain
  • 8.2 Adrenocortical Hormones API Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Adrenocortical Hormones API Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Adrenocortical Hormones API Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Adrenocortical Hormones API Market Trends
  • Table 2. Adrenocortical Hormones API Market Drivers & Opportunity
  • Table 3. Adrenocortical Hormones API Market Challenges
  • Table 4. Adrenocortical Hormones API Market Restraints
  • Table 5. Global Adrenocortical Hormones API Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Adrenocortical Hormones API Revenue Market Share by Company (2020-2025)
  • Table 7. Global Adrenocortical Hormones API Sales Volume by Company (2020-2025) & (Tons)
  • Table 8. Global Adrenocortical Hormones API Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Adrenocortical Hormones API Price by Company (2020-2025) & (US$/kg)
  • Table 10. Key Manufacturers Adrenocortical Hormones API Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Adrenocortical Hormones API Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Adrenocortical Hormones API
  • Table 13. Global Adrenocortical Hormones API Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Adrenocortical Hormones API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Adrenocortical Hormones API Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Adrenocortical Hormones API Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Adrenocortical Hormones API Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Adrenocortical Hormones API Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Adrenocortical Hormones API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
  • Table 22. Global Adrenocortical Hormones API Sales Volume by Type (2020-2025) & (Tons)
  • Table 23. Global Adrenocortical Hormones API Sales Volume by Type (2026-2031) & (Tons)
  • Table 24. Global Adrenocortical Hormones API Sales Volume Market Share by Type (2020-2025)
  • Table 25. Global Adrenocortical Hormones API Sales Volume Market Share by Type (2026-2031)
  • Table 26. Global Adrenocortical Hormones API Price by Type (2020-2025) & (US$/kg)
  • Table 27. Global Adrenocortical Hormones API Price by Type (2026-2031) & (US$/kg)
  • Table 28. Global Adrenocortical Hormones API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Adrenocortical Hormones API Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Adrenocortical Hormones API Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Adrenocortical Hormones API Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Adrenocortical Hormones API Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Adrenocortical Hormones API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
  • Table 34. Global Adrenocortical Hormones API Sales Volume by Application (2020-2025) & (Tons)
  • Table 35. Global Adrenocortical Hormones API Sales Volume by Application (2026-2031) & (Tons)
  • Table 36. Global Adrenocortical Hormones API Sales Volume Market Share by Application (2020-2025)
  • Table 37. Global Adrenocortical Hormones API Sales Volume Market Share by Application (2026-2031)
  • Table 38. Global Adrenocortical Hormones API Price by Application (2020-2025) & (US$/kg)
  • Table 39. Global Adrenocortical Hormones API Price by Application (2026-2031) & (US$/kg)
  • Table 40. Global Adrenocortical Hormones API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Adrenocortical Hormones API Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Adrenocortical Hormones API Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Adrenocortical Hormones API Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Adrenocortical Hormones API Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Adrenocortical Hormones API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
  • Table 46. Global Adrenocortical Hormones API Sales Volume by Region (2020-2025) & (Tons)
  • Table 47. Global Adrenocortical Hormones API Sales Volume by Region (2026-2031) & (Tons)
  • Table 48. Global Adrenocortical Hormones API Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Adrenocortical Hormones API Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Adrenocortical Hormones API Average Price by Region (2020-2025) & (US$/kg)
  • Table 51. Global Adrenocortical Hormones API Average Price by Region (2026-2031) & (US$/kg)
  • Table 52. Key Countries/Regions Adrenocortical Hormones API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Adrenocortical Hormones API Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Adrenocortical Hormones API Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Adrenocortical Hormones API Sales Volume, (2020-2025) & (Tons)
  • Table 56. Key Countries/Regions Adrenocortical Hormones API Sales Volume, (2026-2031) & (Tons)
  • Table 57. Pfizer CentreOne Company Information
  • Table 58. Pfizer CentreOne Introduction and Business Overview
  • Table 59. Pfizer CentreOne Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 60. Pfizer CentreOne Adrenocortical Hormones API Product Offerings
  • Table 61. Pfizer CentreOne Recent Development
  • Table 62. EUROAPI Company Information
  • Table 63. EUROAPI Introduction and Business Overview
  • Table 64. EUROAPI Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 65. EUROAPI Adrenocortical Hormones API Product Offerings
  • Table 66. EUROAPI Recent Development
  • Table 67. GlaxoSmithKline Company Information
  • Table 68. GlaxoSmithKline Introduction and Business Overview
  • Table 69. GlaxoSmithKline Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. GlaxoSmithKline Adrenocortical Hormones API Product Offerings
  • Table 71. GlaxoSmithKline Recent Development
  • Table 72. Teva Pharmaceutical Industries Company Information
  • Table 73. Teva Pharmaceutical Industries Introduction and Business Overview
  • Table 74. Teva Pharmaceutical Industries Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 75. Teva Pharmaceutical Industries Adrenocortical Hormones API Product Offerings
  • Table 76. Teva Pharmaceutical Industries Recent Development
  • Table 77. Hovione Company Information
  • Table 78. Hovione Introduction and Business Overview
  • Table 79. Hovione Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 80. Hovione Adrenocortical Hormones API Product Offerings
  • Table 81. Hovione Recent Development
  • Table 82. Axplora Company Information
  • Table 83. Axplora Introduction and Business Overview
  • Table 84. Axplora Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 85. Axplora Adrenocortical Hormones API Product Offerings
  • Table 86. Axplora Recent Development
  • Table 87. Steroid SpA Company Information
  • Table 88. Steroid SpA Introduction and Business Overview
  • Table 89. Steroid SpA Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 90. Steroid SpA Adrenocortical Hormones API Product Offerings
  • Table 91. Steroid SpA Recent Development
  • Table 92. Avik Pharmaceutical Company Information
  • Table 93. Avik Pharmaceutical Introduction and Business Overview
  • Table 94. Avik Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 95. Avik Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 96. Avik Pharmaceutical Recent Development
  • Table 97. Anuh Pharma Company Information
  • Table 98. Anuh Pharma Introduction and Business Overview
  • Table 99. Anuh Pharma Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 100. Anuh Pharma Adrenocortical Hormones API Product Offerings
  • Table 101. Anuh Pharma Recent Development
  • Table 102. Symbiotec Pharmalab Company Information
  • Table 103. Symbiotec Pharmalab Introduction and Business Overview
  • Table 104. Symbiotec Pharmalab Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 105. Symbiotec Pharmalab Adrenocortical Hormones API Product Offerings
  • Table 106. Symbiotec Pharmalab Recent Development
  • Table 107. Sun Pharmaceutical Company Information
  • Table 108. Sun Pharmaceutical Introduction and Business Overview
  • Table 109. Sun Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 110. Sun Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 111. Sun Pharmaceutical Recent Development
  • Table 112. Cipla Company Information
  • Table 113. Cipla Introduction and Business Overview
  • Table 114. Cipla Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 115. Cipla Adrenocortical Hormones API Product Offerings
  • Table 116. Cipla Recent Development
  • Table 117. Wellona Pharma Company Information
  • Table 118. Wellona Pharma Introduction and Business Overview
  • Table 119. Wellona Pharma Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 120. Wellona Pharma Adrenocortical Hormones API Product Offerings
  • Table 121. Wellona Pharma Recent Development
  • Table 122. Tianjin Tianyao Pharmaceuticals Company Information
  • Table 123. Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
  • Table 124. Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 125. Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Offerings
  • Table 126. Tianjin Tianyao Pharmaceuticals Recent Development
  • Table 127. Zhejiang Xianju Pharmaceutical Company Information
  • Table 128. Zhejiang Xianju Pharmaceutical Introduction and Business Overview
  • Table 129. Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 130. Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 131. Zhejiang Xianju Pharmaceutical Recent Development
  • Table 132. Guangdong Vtr Bio-Tech Company Information
  • Table 133. Guangdong Vtr Bio-Tech Introduction and Business Overview
  • Table 134. Guangdong Vtr Bio-Tech Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 135. Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Offerings
  • Table 136. Guangdong Vtr Bio-Tech Recent Development
  • Table 137. Zhejiang Xianju Xianle Pharmaceutical Company Information
  • Table 138. Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
  • Table 139. Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 140. Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 141. Zhejiang Xianju Xianle Pharmaceutical Recent Development
  • Table 142. TIANJIN PACIFIC PHARMACEUTICAL Company Information
  • Table 143. TIANJIN PACIFIC PHARMACEUTICAL Introduction and Business Overview
  • Table 144. TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 145. TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Offerings
  • Table 146. TIANJIN PACIFIC PHARMACEUTICAL Recent Development
  • Table 147. Shandong Xinhua Pharmaceutica Group Company Information
  • Table 148. Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
  • Table 149. Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 150. Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Offerings
  • Table 151. Shandong Xinhua Pharmaceutica Group Recent Development
  • Table 152. Jiangsu Lianhuan Pharmaceutical Company Information
  • Table 153. Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
  • Table 154. Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 155. Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 156. Jiangsu Lianhuan Pharmaceutical Recent Development
  • Table 157. Shanghai New Hualian Pharmaceutical Company Information
  • Table 158. Shanghai New Hualian Pharmaceutical Introduction and Business Overview
  • Table 159. Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 160. Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 161. Shanghai New Hualian Pharmaceutical Recent Development
  • Table 162. Shandong Taihua Biotech Company Information
  • Table 163. Shandong Taihua Biotech Introduction and Business Overview
  • Table 164. Shandong Taihua Biotech Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 165. Shandong Taihua Biotech Adrenocortical Hormones API Product Offerings
  • Table 166. Shandong Taihua Biotech Recent Development
  • Table 167. Saituo Biological Technology Company Information
  • Table 168. Saituo Biological Technology Introduction and Business Overview
  • Table 169. Saituo Biological Technology Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 170. Saituo Biological Technology Adrenocortical Hormones API Product Offerings
  • Table 171. Saituo Biological Technology Recent Development
  • Table 172. Zhejiang Xianju Junye Pharmaceutical Company Information
  • Table 173. Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
  • Table 174. Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 175. Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Offerings
  • Table 176. Zhejiang Xianju Junye Pharmaceutical Recent Development
  • Table 177. Key Raw Materials Lists
  • Table 178. Raw Materials Key Suppliers Lists
  • Table 179. Adrenocortical Hormones API Downstream Customers
  • Table 180. Adrenocortical Hormones API Distributors List
  • Table 181. Research Programs/Design for This Report
  • Table 182. Key Data Information from Secondary Sources
  • Table 183. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Adrenocortical Hormones API Product Picture
  • Figure 2. Global Adrenocortical Hormones API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Adrenocortical Hormones API Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Adrenocortical Hormones API Sales Volume (2020-2031) & (Tons)
  • Figure 5. Global Adrenocortical Hormones API Sales Price (2020-2031) & (US$/kg)
  • Figure 6. Adrenocortical Hormones API Report Years Considered
  • Figure 7. Global Adrenocortical Hormones API Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Adrenocortical Hormones API Players Sales Volume Ranking (2024) & (Tons)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Adrenocortical Hormones API Revenue in 2024
  • Figure 10. Adrenocortical Hormones API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Prednisone Series Picture
  • Figure 12. Dexamethasone Series Picture
  • Figure 13. Betamethasone Series Picture
  • Figure 14. Hydrocortisone Series Picture
  • Figure 15. Others Picture
  • Figure 16. Global Adrenocortical Hormones API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Adrenocortical Hormones API Sales Value Market Share by Type, 2024 & 2031
  • Figure 18. Global Adrenocortical Hormones API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
  • Figure 19. Global Adrenocortical Hormones API Sales Volume Market Share by Type, 2024 & 2031
  • Figure 20. Global Adrenocortical Hormones API Price by Type (2020-2031) & (US$/kg)
  • Figure 21. Product Picture of Injectable Drugs
  • Figure 22. Product Picture of Oral Drugs
  • Figure 23. Product Picture of Topical Drugs
  • Figure 24. Product Picture of Inhaled Drugs
  • Figure 25. Global Adrenocortical Hormones API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 26. Global Adrenocortical Hormones API Sales Value Market Share by Application, 2024 & 2031
  • Figure 27. Global Adrenocortical Hormones API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
  • Figure 28. Global Adrenocortical Hormones API Sales Volume Market Share by Application, 2024 & 2031
  • Figure 29. Global Adrenocortical Hormones API Price by Application (2020-2031) & (US$/kg)
  • Figure 30. North America Adrenocortical Hormones API Sales Value (2020-2031) & (US$ Million)
  • Figure 31. North America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Europe Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Asia Pacific Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Asia Pacific Adrenocortical Hormones API Sales Value by Region (%), 2024 VS 2031
  • Figure 36. South America Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. South America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Middle East & Africa Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Middle East & Africa Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
  • Figure 40. Key Countries/Regions Adrenocortical Hormones API Sales Value (%), (2020-2031)
  • Figure 41. Key Countries/Regions Adrenocortical Hormones API Sales Volume (%), (2020-2031)
  • Figure 42. United States Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. United States Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 44. United States Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Europe Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Europe Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Europe Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 48. China Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. China Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 50. China Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Japan Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. Japan Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 53. Japan Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 54. South Korea Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. South Korea Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 56. South Korea Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 57. Southeast Asia Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. Southeast Asia Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 59. Southeast Asia Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 60. India Adrenocortical Hormones API Sales Value, (2020-2031) & (US$ Million)
  • Figure 61. India Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • Figure 62. India Adrenocortical Hormones API Sales Value by Application (%), 2024 VS 2031
  • Figure 63. Adrenocortical Hormones API Industrial Chain
  • Figure 64. Adrenocortical Hormones API Manufacturing Cost Structure
  • Figure 65. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed